SEC Form D · filed March 3, 2023
Checkpoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Barry F. Salzman · Waltham, MADirectorScott A. Boilen · Waltham, MADirectorJames F. Oliviero, Iii · Waltham, MAExec · DirectorMichael F. Weiss · Waltham, MADirectorChristian F. Bechon · Waltham, MADirectorGarrett F. Gray · Waltham, MAExecLindsay A. Rosenwald · Waltham, MADirectorNeil F. Herskowitz · Waltham, MADirectorManuel E. Tarrasa Sanchez · Madrid, U3DirectorAshley Mayer · Dover, DEDirectorAlex Koglin · Santa Fe, NMDirectorJose M. Moran Adarraga · Madrid, U3DirectorStuart Orgill · San Francisco, CAExecToyin Ajayi · Dover, DEDirectorMarco M. Buhigas Moran · Madrid, U3Exec · DirectorBarbara Serrano Sanchez · Madrid, U3DirectorDavid Carew · Toronto, Ontario, CanadaExec · DirectorMaxim D. Crewe · London, United KingdomExecThomas P. Railhac · London, United KingdomDirectorSven Gosta P. Pattersson · London, United KingdomDirectorSimon B. Creswell · St Peter Port, Y7DirectorHiroaki Kobayashi · BALTIMORE, MDDirectorJeffrey Cleland · BALTIMORE, MDDirectorAkihiro Ko · BALTIMORE, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗